Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow FIREFLY NEUROSCIENCE, INC.

Get SEC filing alerts via email and in your feed for FIREFLY NEUROSCIENCE, INC.

AIFF

FIREFLY NEUROSCIENCE, INC.

About FIREFLY NEUROSCIENCE, INC.

Firefly Neuroscience develops AI-driven neurophysiological assessment tools, notably the FDA-cleared BNA Platform, which analyzes EEG data to aid in diagnosing and managing neurological and mental health disorders. Its solutions support personalized treatment, clinical research, and drug development, targeting healthcare providers and pharmaceutical companies. Leveraging extensive proprietary databases and advanced machine learning, the company aims to transform brain health diagnostics and improve patient outcomes.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from FIREFLY NEUROSCIENCE, INC.

1
1
FIREFLY NEUROSCIENCE, INC. Firefly Neuroscience Reports 1,028% Revenue Growth and Improved Net Loss in Latest 10-Q Filing

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
FIREFLY NEUROSCIENCE, INC. Firefly Neuroscience Reports 957% Revenue Growth to $1.142 Million in 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
FIREFLY NEUROSCIENCE, INC. Firefly Neuroscience Reports 1,076% Revenue Increase and Strategic Acquisition in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
FIREFLY NEUROSCIENCE, INC. Firefly Neuroscience Reports 2,891% Revenue Increase and Acquisition of Evoke Neuroscience

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
FIREFLY NEUROSCIENCE, INC. Firefly Neuroscience Reports 258% Revenue Growth but Incurred $17.34 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
FIREFLY NEUROSCIENCE, INC. Firefly Neuroscience Reports 76% Revenue Decline and $10.1 Million Operating Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
FIREFLY NEUROSCIENCE, INC. Firefly Neuroscience Reports Significant Asset Growth, Revenue Decline, and Operating Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments